Safety profile comparison of chimeric live attenuated and Vero cell-derived inactivated Japanese encephalitis vaccines through an active surveillance system in Australia
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety profile comparison of chimeric live attenuated and Vero cell-derived inactivated Japanese encephalitis vaccines through an active surveillance system in Australia
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume 18, Issue 1, Pages -
Publisher
Informa UK Limited
Online
2022-03-08
DOI
10.1080/21645515.2021.2020573
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adverse events following immunization with the live-attenuated recombinant Japanese encephalitis vaccine (IMOJEV®) in Taiwan, 2017–18
- (2020) Hsuan-Yin Ma et al. VACCINE
- Post-Marketing Surveillance of Adverse Events Following Vaccination with the Live-Attenuated Japanese Encephalitis Chimeric Virus Vaccine (Imojev®) in South Korea, 2015–2019
- (2020) Hee Soo Kim et al. Infectious Diseases and Therapy
- Adverse events following vaccination with an inactivated, Vero cell culture-derived Japanese encephalitis vaccine in the United States, 2012–2016
- (2018) William L. Walker et al. VACCINE
- Safety and immunogenicity of an inactivated Vero cell_derived Japanese encephalitis vaccine (IXIARO ® , JESPECT ® ) in a pediatric population in JE non-endemic countries: An uncontrolled, open-label phase 3 study
- (2018) Tomas Jelinek et al. Travel Medicine and Infectious Disease
- Post-licensure, phase IV, safety study of a live attenuated Japanese encephalitis recombinant vaccine in children in Thailand
- (2017) Tawee Chotpitayasunondh et al. VACCINE
- Refusal of recommended travel-related vaccines among U.S. international travellers in Global TravEpiNet
- (2016) Sara M. Lammert et al. JOURNAL OF TRAVEL MEDICINE
- Safety and immunogenicity of a live attenuated Japanese encephalitis chimeric virus vaccine (IMOJEV®) in children
- (2015) K Chokephaibulkit et al. Expert Review of Vaccines
- Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)
- (2015) Tom T. Shimabukuro et al. VACCINE
- Evaluation of rabies immunogenicity and tolerability following a purified chick embryo cell rabies vaccine administered concomitantly with a Japanese encephalitis vaccine
- (2015) Tomas Jelinek et al. Travel Medicine and Infectious Disease
- Using automated text messages to monitor adverse events following immunisation in general practice
- (2014) Alan Leeb et al. MEDICAL JOURNAL OF AUSTRALIA
- Concomitant administration of live attenuated Japanese encephalitis chimeric virus vaccine (JE-CV) and measles, mumps, rubella (MMR) vaccine: Randomized study in toddlers in Taiwan
- (2014) Li-Min Huang et al. VACCINE
- Long term immunity to live attenuated Japanese encephalitis chimeric virus vaccine
- (2011) Peter E. Nasveld et al. Human vaccines & immunotherapeutics
- Epidemiology of viral encephalitis in 2011
- (2011) J.-P. Stahl et al. MEDECINE ET MALADIES INFECTIEUSES
- Safety profile of the Vero cell-derived Japanese encephalitis virus (JEV) vaccine IXIARO®
- (2011) Elisabeth Schuller et al. VACCINE
- Effectiveness of mouse brain-derived inactivated Japanese encephalitis vaccine in Thai National Immunization Program: A case–control study
- (2011) Charung Muangchana et al. VACCINE
- Surveillance for Japanese Encephalitis in Vietnam, 1998–2007
- (2010) Nguyen Thu Yen et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Safety analysis of a Vero-cell culture derived Japanese encephalitis vaccine, IXIARO® (IC51), in 6 months of follow-up
- (2010) Katrin Dubischar-Kastner et al. VACCINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search